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ABSTRACT
Background In the UK, free smoking cessation
support is available to pregnant women; only a minority
accesses this. ‘Opt-out’ referrals to stop smoking services
(SSS) are recommended by UK guidelines. These involve
identifying pregnant smokers using exhaled carbon
monoxide (CO) and referring them for support unless
they object.
Methods To assess the impact of ‘opt-out’ referrals for
pregnant smokers on SSS uptake and effectiveness, we
conducted a ‘before–after’ service development
evaluation. In the 6-month ‘before’ period, there was a
routine ‘opt-in’ referral system for self-reported smokers
at antenatal ‘booking’ appointments. In the 6-month
‘after’ period, additional ‘opt-out’ referrals were
introduced at the 12-week ultrasound appointments;
women with CO≥4 ppm were referred to, and outcome
data were collected from, local SSS.
Results Approximately 2300 women attended
antenatal care in each period. Before the
implementation, 536 (23.4%) women reported smoking
at ‘booking’ and 290 (12.7%) were referred to SSS.
After the implementation, 524 (22.9%) women reported
smoking at ‘booking’, an additional 156 smokers (6.8%)
were identiﬁed via the ‘opt-out’ referrals and, in total,
421 (18.4%) were referred to SSS. Over twice as many
women set a quit date with the SSS after ‘opt-out’
referrals were implemented (121 (5.3%, 95% CI 4.4%
to 6.3%) compared to 57 (2.5%, 95% CI 1.9% to
3.2%) before implementation) and reported being
abstinent 4 weeks later (93 (4.1%, 95% CI 3.3% to
4.9%) compared to 46 (2.0%, 1.5% to 2.7%) before
implementation).
Conclusions In a hospital with an ‘opt-in’ referral
system, adding CO screening with ‘opt-out’ referrals as
women attended ultrasound examinations doubled the
numbers of pregnant smokers setting quit dates and
reporting smoking cessation.
INTRODUCTION
Smoking in pregnancy increases the risks of miscar-
riage, stillbirth, prematurity, low birth weight, peri-
natal morbidity and mortality, sudden infant death,
asthma,1 learning difﬁculties,2 obesity and dia-
betes.3 It is a substantial public health problem in
high-income countries; for example, 26% of UK
women smoke at some point in pregnancy;4 in
Japan5 and Canada,6 the prevalence rate is around
10%. Less robust data are available from low-
income countries, but the WHO anticipates an
epidemic of smoking in pregnancy within these
jurisdictions.7 Eliminating smoking in pregnancy
should be a priority for healthcare systems inter-
nationally. Additionally, as children of smokers are
more likely to start smoking themselves,8 9 when
pregnant women achieve permanent cessation,
longer term beneﬁts may occur as a consequence of
lower smoking rates in their children as adults.
Pregnancy is a life event that strongly motivates
women to stop smoking; approximately half of UK
women who smoke attempt cessation after concep-
tion,9 and there are effective interventions that can
help them.10 11 Although a few countries systemat-
ically provide smoking cessation support for preg-
nant women, this has been offered in the UK via
the National Health Service (NHS) Stop Smoking
Services (SSS) since 2000.12 Despite SSS being free
of charge and widely available, only around 12%
of pregnant smokers access this support; however,
nearly half of those who do report quitting for at
least 4 weeks.13
The need to improve the uptake of cessation
support has focused attention on methods for
engaging with pregnant women. WHO14 recom-
mends that all women’s smoking status should be
assessed early in pregnancy to ensure that all preg-
nant smokers receive prompt cessation support.
Until recently, UK midwives asked women about
smoking at their ﬁrst (‘booking’) antenatal appoint-
ment at 8–12 weeks of gestation and referred those
who requested support to the SSS (‘opt-in’ refer-
rals). When using self-report, up to 25% of
smokers fail to disclose their smoking;15 16
however, identiﬁcation of smokers at booking using
exhaled carbon monoxide (CO) was only reported
by 50% of SSS in the UK in 2010–2011.17
Opportunities to screen for smoking at subsequent
pregnancy appointments, such as at the ultrasound
dating scan, routinely performed at around 12
weeks of gestation, are also missed. The UK
National Institute for Health and Care Excellence
(NICE) recommends that exhaled CO screening
should be used to identify smokers in early preg-
nancy, and those who do not speciﬁcally object
should be referred for support; such referrals are
known as ‘opt-out’ referrals.18 Evidence for the
efﬁcacy of this approach is limited to two studies:
an observational audit of Scottish SSS, where the
few SSS which were then using CO identiﬁcation
and ‘opt-out’ referrals were noted to have higher
referral rates;19 and a ‘before–after’ study that
monitored referrals to SSS from two UK hospi-
tals.20 This latter study suggested that, after new
referral processes began, referral numbers increased
but women’s smoking cessation did not; however,
Campbell KA, et al. Tob Control 2016;0:1–7. doi:10.1136/tobaccocontrol-2015-052662 1
Research paper
 TC Online First, published on May 25, 2016 as 10.1136/tobaccocontrol-2015-052662
Copyright Article author (or their employer) 2016. Produced by BMJ Publishing Group Ltd under licence. 
group.bmj.com on December 9, 2016 - Published by http://tobaccocontrol.bmj.com/Downloaded from 
no formal statistical testing was used, hindering interpretation of
ﬁndings.20 A large UK hospital Trust decided to integrate CO
identiﬁcation of smokers and ‘opt-out’ referrals at the ultra-
sound dating scan; our aim was to compare women’s rates of
referral for and engagement with SSS support and of smoking
cessation before and after this change in practice.
METHODS
Study design
New ‘opt-out’ referral procedures with CO identiﬁcation of
smokers when attending their ultrasound dating scan were intro-
duced at Sherwood Forest Hospitals NHS Foundation Trust
(SFHFT), Nottinghamshire, UK between 1 May and 31 October
2013. SFHFT had two antenatal clinics: at Kings Mill Hospital
(KMH) and Sherwood Women’s Centre (SWC). For the study
period, and for a comparison period between 1 May and 31
October 2012, anonymised data on referral processes and
cessation outcomes were collected. Figure 1 shows patient ﬂow
and interventions delivered in both time periods.
This study is a ‘before–after’ evaluation of this service
development.
May–October 2012: Routine practice before ‘opt-out’ referral
implementation
Before the ‘opt-out’ referral pathway was introduced, there were
already well-established procedures for referring pregnant
smokers for cessation support within SFHFT. Routinely, at the
ﬁrst antenatal (‘booking’) appointment (8–12 weeks), midwives
asked women about smoking and self-reported smokers who
agreed were referred to SSS (‘opt-in’ referrals); CO monitors
were not used. ‘Opt-in’ referrals were also offered at 25 and 34
weeks of gestation, at delivery and twice postnatally; however,
few referrals were typically made at these points. Referrals were
sent electronically to Nottinghamshire New Leaf, a community-
Figure 1 Patient ﬂow and interventions at ‘booking’ and at dating scan appointments before and after implementation of the ‘opt-out’ referral
pathway.
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based SSS, via a web-based system, integrated with electronic
medical records (called Orion). Most women also attended two
routine ultrasound appointments at SFHFT: a 12-week dating
scan and a 20-week anomaly scan; smoking was not routinely
discussed at these.
May–October 2013: Changes to practice after ‘opt-out’ referral
implementation
CO identiﬁcation of smokers and ‘opt-out’ referrals were
piloted in April 2013, and implemented, after routine ‘opt-in’
referrals at booking, between May and October 2013. This was
implemented at the 12-week dating scan and was intended for
all pregnant women who attended this appointment, regardless
of their self-reported smoking status at booking. This time point
was chosen as most pregnant women attend the 12-week scan,
it is early in pregnancy and routine smoking cessation support
was not offered at this point. We worked closely with SFHFT to
integrate data collection into electronic medical records. The
‘opt-out’ referral pathway was implemented by ﬁve healthcare
assistants at KMH and a midwife at SWC. All antenatal staff
received a full-day training delivered by the National Centre for
Smoking Cessation Training (NCSCT) based on evidence-based
behaviour change techniques,21 and including risks of smoking
in pregnancy; beneﬁts of and challenges in smoking cessation;
using CO monitors; interpreting CO readings; explaining risks
associated with high CO; and making electronic referrals.
Written materials reinforced oral presentations and group work.
The protocol for delivering ‘opt-out’ referrals which healthcare
assistants followed is described in ﬁgure 2. CO testing/referrals
were prompted by the electronic medical record system. The
pathway was integrated with routine observations, like blood
pressure, which were already being made by these staff immedi-
ately after ultrasound examinations. The CO level ≥4 ppm was
used to identify smokers based on NICE recommendations;18
past research20 found 4 ppm to be optimal in pregnancy. An
additional healthcare assistant was appointed to work 20 hours/
week for 6 months, managing any workload increase. An ante-
natal clinic manager acted as a local ‘champion’, overseeing the
implementation and supporting the staff with new tasks. Similar
to the ‘opt-in’ referrals, the ‘opt-out’ referrals were sent to SSS
electronically via the Orion system. Staff were also monitored
and supported by the research team.
Smoking cessation support offered by SSS
Nottinghamshire New Leaf offered identical supportive inter-
ventions to all pregnant smokers referred in both periods. Staff
attempted to call each woman twice, and if a woman was
uncontactable, they sent a letter detailing ways to contact the
SSS for support. Women who engaged with the service were
encouraged to set a quit date and were offered weekly behav-
ioural support for up to 12 weeks, and up to 12 weeks of nico-
tine replacement therapy in fortnightly batches on an abstinent–
contingent basis at no-cost to them. The behavioural support
offered to women was based on the NICE guidelines18 and
Figure 2 Protocol for ‘opt out’ referrals followed by healthcare assistants.
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NCSCT Standard Treatment Programme.22 After implementa-
tion, a role of ‘pregnancy lead’ was established within the
service. She spent one half-day per week at the antenatal clinic,
offering immediate support to pregnant smokers; this was dis-
continued due to the lack of demand.
Data collection and participants
Anonymised, individual-level data were collected from two
routine sources (ﬁgure 3). First, the Orion system provided
‘booking’ appointment data on the number of women receiving
antenatal care and their smoking behaviour; this was also used
for information about the ultrasound appointment. These data
were obtained for all women presenting for antenatal care in
each period. Second, from the SSS ‘QuitManager’ (North 51
HealthWare) database, we collected the available background
information and outcome data. These data were collected for all
pregnant women referred to the SSS from SFHFT via the
‘opt-in’ and/or ‘opt-out’ referrals.
Study outcomes
After collection, data from both sources (ﬁgure 3) were cross-
referenced to ensure accuracy and eliminate duplicate records.
Engagement
The primary study outcome and the one on which the study
was powered (see below) was women’s engagement with the
SSS, deﬁned as setting a quit date with SSS support, during
pregnancy. Only women whom the SSS successfully contacted
within 24 weeks after their referral were included in analyses,
ensuring that women who engaged with SSS support after preg-
nancy were excluded. To ensure that only independent cases
were analysed, individuals could only appear once in the data
set and could only have one outcome. Only 10 women had
more than one eligible record on QuitManager (1.4% of all
referred). Where this occurred, we used the outcome of the
latest record in pregnancy. As SSS offered pregnant smokers
evidence-based support with cessation, engagement was consid-
ered an important outcome as greater engagement could be
expected to result in more women stopping smoking.
Smoking cessation
At the time of the study in the UK, abstinence from smoking of
an at least 2-week duration recorded at 4 weeks after starting a
quit attempt was a mandatory outcome which the SSS reported
to the English Department of Health; hence, these data were
routinely available for all SSS clients.23 As study intervention
was anticipated to affect women’s engagement with the SSS and
no substantial changes were made to the cessation support pro-
vided by the SSS, the 4-week post quit date cessation was con-
sidered an appropriate secondary outcome to measure the
effectiveness of the ‘opt-out’ referral pathway.
Data analysis
Sample size estimation
At the time of our a priori sample size estimation, we had access
only to data from KMH, one of the two SFHFT hospitals;
hence, our sample size estimate was conservative as the esti-
mated throughput of smokers to SFHFT used was lower than
the actual number of women attending antenatal care at both
hospitals. As ∼800 women attended antenatal care at SWC
annually, the actual number of women eligible for referral in
each study period at both hospitals was around 800 higher than
that in the sample size estimate below.
At KMH, in the 12 months before April 2012, 3286 women
were booked; of those, 27.2% were smokers, 11.5% were
referred to the local SSS and 3.0% set a quit date. Therefore, in
each of the two study periods (ie, ‘before’ and ‘after’ interven-
tion) anticipated to be 6 months long, at least 1684 pregnant
women would be available for referral and a similar rate of
‘setting a quit date’ (ie, 3.0%) could be estimated with a 95%
CI of 2.2% to 3.8% (±0.8% margin). We believed that a 1.5%
absolute increase (ie, to 4.5%) in the proportion of pregnant
women setting a quit date would be a positive outcome, and the
study was powered such that this could be determined with a
95% CI of 0.137% to 0.163% (±0.13%).
Data analysis
Proportions of all women presenting for antenatal care who set
a quit date and reported abstinence from smoking 4 weeks later
are presented with 95% CIs, together with the difference in
proportions between the study periods, again with 95% CIs. We
report outcomes within pregnant women rather than within
smokers because the method of identifying smokers varied in
the two time periods and, hence, the population of pregnant
women provided a denominator that was not prone to vary
between periods. 95% CIs for single proportions were based on
the Wilson method,24 and 95% CIs for the difference between
two proportions were estimated based on the Newcombe-
Wilson method without continuity correction.25 We also present
descriptive statistics on the numbers of pregnant women receiv-
ing antenatal care and the proportions of smokers identiﬁed by
usual Trust procedures at ‘booking’ for the two time periods.
For the ‘after’ period, we present the number (percentages) of
women offered/accepting CO tests and referred to SSS. Key
characteristics of referred women are compared in study periods
Figure 3 Data sources and data collected.
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using χ2 and t-tests. As our analysis was based on routinely col-
lected data, only information relating to age and socioeconomic
status represented by the Index of Multiple Deprivations
derived from postcode were of sufﬁcient completeness for com-
parison. All analyses were carried out in Stata V.13.1 (StataCorp
LP, USA).
RESULTS
Identiﬁcation of smokers at ‘booking’ and 12-week scan
appointments
There were 2287 women booked for maternity care at SFHFT
before and 2293 after implementation of the ‘opt-out’ referrals.
As shown in ﬁgure 1, there were similar proportions of women
who had their smoking status recorded and who reported
smoking at ‘booking’ in both periods. Furthermore, similar pro-
portions of women attended the scan at SFHFT in each period.
Data on CO testing and ‘opt-out’ referrals at the 12-week
dating scan are also presented in ﬁgure 1. As a result of the CO
testing, 506 women (22.1%) were identiﬁed as smokers; of
these, 350 had already reported being a smoker at ‘booking’,
whereas a further 156, amounting to 22.9% of all smokers
identiﬁed in this period, had not reported smoking at booking
and were only identiﬁed as smokers via the CO testing.
Overall, 536 individuals (22.8%) were identiﬁed as smokers in
the period before and 680 (29.7%) in the period after imple-
mentation (524 at booking and an additional 156 at the dating
scan).
Outcomes of referrals received by SSS
Table 1 summarises that the proportion of all pregnant women
who set a quit date with the SSS more than doubled in the
period after implementation of the ‘opt-out’ referral pathway,
equating to a signiﬁcant increase of 2.8% (95% CI 1.7% to
3.9%). Furthermore, the proportion of all pregnant women
who at 4 weeks after their quit date reported smoking cessation
of an at least 2-week duration also doubled after implementa-
tion, equating to a signiﬁcant overall increase of 2.1% (95% CI
1.1% to 3.1%).
There was also a signiﬁcant increase in the proportion of
women referred to the SSS—12.7% (95% CI 11.4% to 14.1%)
of women were referred in the period before versus 18.4%
(95% CI 16.8% to 20%) after implementation of the ‘opt-out’
pathway. After implementation, 177 referrals were made at
‘booking’ and 323 during the dating scan appointments. Out of
the 421 women referred after implementation, 98 women were
referred at ‘booking’ only, 79 women were referred at both
‘booking’ and via the ‘opt-out’ pathway, and 244 women were
referred via the ‘opt-out’ pathway only (data not in the table).
Furthermore, among women who were referred to the SSS,
the quit rate before implementation was 15.9% (46 of 290)
(95% CI 12.1% to 20.5%) compared to 22.1% (93 of 421)
afterwards (95% CI 18.4% to 26.3%, p=0.04).
Characteristics of women referred before and after
introduction of the ‘opt-out’ pathway
Table 2 contrasts characteristics of the women who set a quit
date in both time periods. These suggest that women setting a
quit date in both periods were of similar age (t=0.1226,
p=0.9026) and came from equally highly deprived areas
(χ2=2.8263, p=0.587).
DISCUSSION
Introducing ‘opt-out’ referrals with CO identiﬁcation of
smokers at 12-week dating ultrasound scan appointments sub-
stantially increased the numbers of referrals for smoking cessa-
tion support received by the local SSS. Consequently, twice the
number of women receiving antenatal care engaged with SSS
support in the period after implementation. Crucially, there was
also a doubling in the proportion of pregnant women who at
1 month after their quit date reported abstinence from smoking
and an unexpected 6% statistically signiﬁcant increase in suc-
cessful cessation among women who used SSS in the interven-
tion period.
The non-randomised study design means that there may be
alternative explanations for our ﬁndings; we cannot, with abso-
lute certainty, attribute these to the intervention. However, by
using a time-matched comparison period, we have controlled
for the potential effects of annual stop smoking campaigns, such
as ‘Stoptober’.26 Furthermore, similar numbers of women
received antenatal care before and after the intervention and
similar patterns of smoking behaviours at the outset of mater-
nity care were observed; so, it also seems unlikely that differ-
ences in smoking habits between the two periods could explain
the ﬁndings. Also, SFHFT made no other changes to pregnant
smokers’ referral procedures and the local SSS did not imple-
ment alterations to their response to referrals. Finally, national
data presented to the Department of Health by the SSS suggest
that, in 2013, the proportion of pregnant smokers who set quit
dates with SSS support fell for the second consecutive year
across the UK, so the increase we observed was against the
national trend.13 Therefore, it seems most likely that the new
referral procedures were responsible for women’s increased ces-
sation activity.
Generalisability of ﬁndings is potentially an issue; referral
procedures were introduced into an acute hospital trust serving
a disadvantaged neighbourhood in the East Midlands, UK,
where awareness of SSS is likely to be poor and smoking rates at
the time of delivery are signiﬁcantly higher than the national
average (21% vs 12%, respectively, in 2013–2014).27 Although
our ﬁndings may be most generalisable to maternity hospitals in
Table 1 Referrals of pregnant smokers received by stop smoking services and outcomes before and after implementation of the ‘opt-out’
referral pathway
Before: May–October 2012 After: May–October 2013 Difference in
proportions
(95% CI), (p value)N Per cent 95% CI N Per cent 95% CI
Women receiving antenatal care 2287 2293 NA
Referrals received by stop smoking services 290 12.7 11.4 to 14.1 421 18.4 16.8 to 20.0 5.7 (3.6 to 7.8)†
Women who set a quit date 57 2.5 1.9 to 3.2 121 5.3 4.4 to 6.3 2.8 (1.7 to 3.9)†
Women who reported stopping smoking 4 weeks after the quit date 46 2.0 1.5 to 2.7 93 4.1 3.3 to 4.9 2.1 (1.1 to 3.1)†
†p<0.001.
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areas with higher than average smoking rates, it is encouraging
that effects observed were additional to those of existing, sys-
tematic ‘opt-in’ referral procedures. Furthermore, 22.9% of all
smokers identiﬁed via the CO test failed to report smoking at
booking; this phenomenon of pregnant smokers concealing
their smoking status has been noted in other studies.15 16
Introducing similar smoker-identiﬁcation and referral methods
into maternity hospitals with a less systematic routine care could
result in even greater improvements in smoking cessation.
Being an evaluation set in a clinical care setting was a study
strength that posed challenges; we used routine rather than
specially collected data to monitor referral processes and
smoking outcomes. Although our cessation outcome was not
CO validated, methods used to collect these data had been long-
established and formed the basis of SSS performance data sub-
mitted to the English Department of Health; although some
smokers might have concealed their smoking at follow-up, there
is no reason to suppose the prevalence of this potential bias
would differ between study periods. We are conﬁdent that all
women referred to SSS from this Trust were identiﬁed.
Although we worked closely with hospital information technol-
ogy staff to integrate the new referrals into the electronic hos-
pital system, some referred women had no Orion record entry
of a CO reading; however, it would be very unlikely for a refer-
ral to be made without CO monitoring. This suggests that the
‘opt-out’ referral pathway may have been implemented more
comprehensively than we have observed, with CO monitoring
being offered to more than 80% (1610 of 2011) of women
attending ultrasound appointments who had this recorded in
their medical records.
Only one other study has assessed the implementation of
near-identical ‘opt-out’ referral processes.20 This study was set
in two West Midlands maternity hospitals and used a ‘before–
after’ design; the authors found an increase in pregnancy refer-
ral numbers, but not in cessation. Proportions setting quit dates
were not reported. We are uncertain why similar referral proce-
dures used in our study had such a positive impact; however, in
our study, referral procedures were implemented more compre-
hensively (80% of women attending scan vs 61% in the West
Midlands) and these were offered at ultrasound appointments
rather than at ‘booking’.20 Seeing the baby for the ﬁrst time,
coupled with getting the CO reading and learning that high CO
levels are harmful to the fetus, could have been an additional
motivator for the women. At SFHFT, ‘opt-out’ referrals were
implemented by a small group of healthcare staff, who were
trained to national standards and received support afterwards;
staff training and ongoing support may be necessary to ensure
that new referral processes are effectively introduced. Finally,
the ‘opt-out’ pathway was implemented in addition to existing
‘opt-in’ referrals, and repeated referrals may have enhanced
smokers’ motivation leading to improved cessation outcomes.
Other reports of ‘opt-out’ referrals are descriptive. In
Glasgow, implementation across three antenatal units was incon-
sistent, with only 55% of pregnant women being offered a CO
test overall; however, this ﬁgure masks variation between differ-
ent hospitals.28 In one, where ancillary nurses conducted refer-
rals, 89% of pregnant women provided CO samples, but in
another where midwives oversaw the process only 35% did.
The healthcare assistants who conducted referrals at SFHFT
would be more similar to the now discontinued auxiliary nurse
grade than midwives, suggesting that responsibility for oversee-
ing these processes is best delegated to health professionals who
routinely deal with the less complex aspects of patient care. Our
ﬁndings indicate that with ongoing support and tailored train-
ing, support staff can effectively implement CO testing with
‘opt-out’ referrals and this process could be easily replicated in
other antenatal hospitals.
In this study, there was a substantial increase in numbers of
pregnant smokers identiﬁed and referred for further support;
this may have additional, longer term effects, as SSS deliver
evidence-based cessation support, which would be expected to
encourage more women to achieve permanent abstinence from
smoking.10 It could allow the SSS to target more women in the
future to re-engage in treatment and prevent return to smoking
after delivery. The additional knowledge imparted during the
screening by trained antenatal staff may also have impacted on
women’s motivation to engage with SSS support and change
general attitudes towards smoking in pregnancy.
Despite early systematic identiﬁcation of pregnant smokers
being recommended by UK national and international guid-
ance,14 18 antenatal staff are cautious about introducing CO
testing with their patients.29 30 By indicating that systematic
implementation of this pathway can improve engagement and
cessation outcomes in pregnancy, study ﬁndings could help
reduce perceived barriers to introducing these procedures.
Implementation of ‘opt-out’ referrals with CO identiﬁcation
of smokers has some ﬁnancial implications, such as staff and
training costs or the cost of CO monitors. The increase in refer-
ral numbers may also affect SSS workload. While detailed eco-
nomic evaluation would be necessary to fully investigate the
cost-effectiveness of ‘opt-out’ referrals, the very positive cessa-
tion outcomes from this evaluation suggest that such further
research is warranted as these methods could prove to be highly
cost-effective.
Table 2 Characteristics of smokers who set a quit date with stop
smoking services before and after the implementation of the
‘opt-out’ referral pathway
Characteristic
Before
(N=57)
After
(N=121) t-test/χ2 (p value)
Age 26.0 25.8 t=0.1226,
Median (IQR) (22.7–30.3) (21.9–30.2) (p=0.9026)
IMD quintile, n (%)
1 (least deprived) 2 (3.5) 1 (0.8)
χ2=2.8263 (p=0.587)
2 4 (7.0) 7 (5.8)
3 10 (17.5) 15 (12.5)
4 17 (29.8) 39 (32.5)
5 (most deprived) 24 (42.1) 58 (48.3)*
*Data on index of multiple deprivation (IMD) quintiles were not available for one of
the women.
What this paper adds
▸ We evaluated the impact of ‘opt-out’ referrals in pregnancy
on stop smoking service (SSS) uptake and effectiveness
within natural settings in one UK hospital Trust.
▸ Our evaluation indicated that ‘opt-out’ referrals with carbon
monoxide screening delivered systematically by dedicated
and trained healthcare assistants at the point of the ﬁrst
antenatal scan have the potential to signiﬁcantly increase
the uptake of cessation support in pregnancy and greatly
improve cessation outcomes.
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CONCLUSIONS
Systematic CO monitoring of all pregnant women with
‘opt-out’ referrals, introduced at the time of the ﬁrst antenatal
ultrasound appointment, has the potential to improve engage-
ment of pregnant smokers with smoking cessation support and
to improve cessation outcomes. This approach could be particu-
larly advantageous in socially deprived areas, where prevalence
of smoking during pregnancy is high and awareness of cessation
services may be low.
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